Award
National Institute of Allergy and Infectious Diseases 5R01AI170617-04
CD103 engagement regulates intestinal IEL effector function
Recipient
Rutgers Biomedical and Health Sciences, Newark, NJ, United States
Award Amount
$659,289.00
Ceiling
$659,289.00
Awarded
January 26, 2026
Identifier
5R01AI170617-04
Research project funded by NIAID to study how CD103 affects intestinal immune cells to enhance mucosal immunity and host defense against infections.
Description
The project aims to investigate the role of CD103 in promoting protective immune responses during enteric infections by studying its effects on intraepithelial lymphocytes (IELs) in the intestine. The research will provide insights into molecular mechanisms of mucosal immunity and host-pathogen interactions.